Consistent with literature data, rare variants in regulatory region of PALB2 were present in 10% of patients, and 29% of the carriers had bilateral tumors with a positive statistical association (P < .001).28 Prophylactic bilateral mastectomy is indicated in several clinical scenarios for women with PALB2 mutations, particularly when BC is identified in one breast. This evidence concerns the gene PALB2 and breast cancer.